Compare Pharma Foods International Co., Ltd. with Similar Stocks
Dashboard
1
The company is Net-Debt Free
- The company is Net-Debt Free
2
High Debt company with Weak Long Term Fundamental Strength
3
Flat results in Apr 26
4
With ROCE of 6.24%, it has a very attractive valuation with a 1.27 Enterprise value to Capital Employed
5
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
JPY 17,215 Million (Small Cap)
31.00
NA
0.00%
0.84
4.92%
1.71
Revenue and Profits:
Net Sales:
16,114 Million
(Quarterly Results - Apr 2026)
Net Profit:
763 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.92%
0%
-4.92%
6 Months
-10.33%
0%
-10.33%
1 Year
-35.45%
0%
-35.45%
2 Years
-35.24%
0%
-35.24%
3 Years
-65.34%
0%
-65.34%
4 Years
-58.86%
0%
-58.86%
5 Years
-79.08%
0%
-79.08%
Pharma Foods International Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.02%
EBIT Growth (5y)
-20.46%
EBIT to Interest (avg)
70.43
Debt to EBITDA (avg)
1.99
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
2.47
Tax Ratio
57.40%
Dividend Payout Ratio
195.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.04%
ROE (avg)
24.44%
Valuation key factors
Factor
Value
P/E Ratio
31
Industry P/E
Price to Book Value
1.50
EV to EBIT
20.41
EV to EBITDA
12.38
EV to Capital Employed
1.27
EV to Sales
0.35
PEG Ratio
0.55
Dividend Yield
NA
ROCE (Latest)
6.24%
ROE (Latest)
4.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Apr'26 - QoQ
Apr'26
Jan'26
Change(%)
Net Sales
16,114.00
16,729.00
-3.68%
Operating Profit (PBDIT) excl Other Income
1,122.00
328.00
242.07%
Interest
49.00
34.00
44.12%
Exceptional Items
0.00
0.00
Consolidate Net Profit
763.00
67.00
1,038.81%
Operating Profit Margin (Excl OI)
57.80%
9.00%
4.88%
USD in Million.
Net Sales
QoQ Growth in quarter ended Apr 2026 is -3.68% vs 6.47% in Jan 2026
Consolidated Net Profit
QoQ Growth in quarter ended Apr 2026 is 1,038.81% vs 103.54% in Jan 2026
Annual Results Snapshot (Consolidated) - Jul'25
Jul'25
Jul'24
Change(%)
Net Sales
65,260.00
62,147.00
5.01%
Operating Profit (PBDIT) excl Other Income
3,154.00
6,021.00
-47.62%
Interest
91.00
62.00
46.77%
Exceptional Items
-118.00
-123.00
4.07%
Consolidate Net Profit
368.00
3,205.00
-88.52%
Operating Profit Margin (Excl OI)
36.30%
82.30%
-4.60%
USD in Million.
Net Sales
YoY Growth in year ended Jul 2025 is 5.01% vs -9.37% in Jul 2024
Consolidated Net Profit
YoY Growth in year ended Jul 2025 is -88.52% vs 4.06% in Jul 2024
About Pharma Foods International Co., Ltd. 
Pharma Foods International Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






